MedTrace Logo

Exposure Therapy for Active Duty Soldiers With Post Traumatic Stress Disorder

NCT01193725 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 162

Last updated 2015-04-14

No results posted yet for this study

Summary

This study is evaluating the efficacy of virtual realty exposure therapy (VRET)by comparing it to prolonged exposure therapy (PE) and a waitlist (WL) group for the treatment of post traumatic stress disorder (PTSD) in active duty (AD) Soldiers with combat-related trauma. The investigators will test the general hypotheses that 10 sessions of VRET or PE will successfully treat PTSD, therapeutically affect levels of physiological arousal, and significantly reduce perceptions of stigma toward seeking behavioral health services.

Conditions

  • Stress Disorders, Post Traumatic

Interventions

BEHAVIORAL

Prolonged Exposure Therapy (PE)

Prolonged exposure therapy will consist of 10 treatment sessions lasting 90 - 120 minutes each, with additional between-session homework assignments.

BEHAVIORAL

Virtual Reality Exposure Therapy (VRET)

Virtual Reality Exposure Therapy will consist of 10 treatment sessions lasting 90 -120 minutes with additional between-session homework assignments.

BEHAVIORAL

Waitlist

This group will refrain from psychotherapy until after the completion of the 5 weeks of study participation

Sponsors & Collaborators

  • University of Southern California

    collaborator OTHER

  • National Center for Telehealth and Technology

    lead FED

Principal Investigators

  • Gregory A Gahm, PhD · DCoE - National Center for Telehealth and Technology

  • Greg Reger, PhD · DCoE - National Center for Telehealth and Technology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2013-11-30
Completion
2014-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01193725 on ClinicalTrials.gov